Declines in either plasma insulin or the sensitivity to insulin in diabetes would be expected to lift its inhibition of cAMP‐mediated responses to glucagon (Gabbay & Lardy, 1984; Illiano & Cuatrecasas, 1972). The gene discussed is INS; the disease is diabetes mellitus.